Anogenital distance in human male and female newborns: a descriptive, cross-sectional study
© Salazar-Martinez et al; licensee BioMed Central Ltd. 2004
Received: 18 March 2004
Accepted: 13 September 2004
Published: 13 September 2004
In animal studies of the effects of hormonally active agents, measurement of anogenital distance (AGD) is now routine, and serves as a bioassay of fetal androgen action. Although measurement of AGD in humans has been discussed in the literature, to our knowledge it has been measured formally in only two descriptive studies of females. Because AGD has been an easy-to-measure, sensitive outcome in animals studies, we developed and implemented an anthropometric protocol for measurement of AGD in human males as well as females.
We first evaluated the reliability of the AGD measures in 20 subjects. Then measurements were taken on an additional 87 newborns (42 females, 45 males). All subjects were from Morelos, Mexico.
The reliability (Pearson r) of the AGD measure was, for females 0.50, and for males, 0.64. The between-subject variation in AGD, however, was much greater than the variation due to measurement error. The AGD measure was about two-fold greater in males (mean, 22 mm) than in females (mean, 11 mm), and there was little overlap in the distributions for males and females.
The sexual dimorphism of AGD in humans comprises prima facie evidence that this outcome may respond to in utero exposure to hormonally active agents.
In animal studies of the effects of hormonally active agents, measurement of anogenital distance (AGD) is now routine [1–16], and serves as a bioassay of fetal androgen action. In rodents, perineal growth is dihydrotestosterone-dependent , males have a greater AGD than females, and use of AGD to sex newborns is standard . In animals AGD is correlated at only modest levels with body weight , because these measures reflect the effects of endocrine axes that are largely independent. AGD usually tracks through life, varies by dose of antiandrogen, and can be predictive of other androgen-responsive outcomes .
Although measurement of AGD in humans has been discussed in the literature [19, 21–23], to our knowledge it has been measured formally in only two descriptive studies of females [24, 25]. Because AGD has been an easy-to-measure, sensitive outcome in animal studies, we developed and implemented an anthropometric protocol for measurement of AGD in human males as well as females. This work constitutes a modest step towards evaluation of AGD in human males as a potentially useful anthropometric measure and indicator of in utero androgen status.
A cross-sectional study was conducted among the newborn children of women admitted for delivery to the Dr. Ernesto Meana San Román General Hospital in Jojutla, Morelos, Mexico, in 1999. This hospital provides medical care to low socioeconomic status and uninsured populations. The study included 87 newborn infants, none of whom had congenital defects or had been admitted to the neonatal intensive care unit. All infants were born at term (≥38 weeks gestation), except for one (32 weeks). The infants were of both sexes and were born after spontaneous cephalic delivery or caesarean section. Within 6 hours of birth, a structured questionnaire about family background and obstetric history was administered to the mothers, and anthropometric measurements were taken on the newborns.
Before any contact with the 87 subjects in the main study, the personnel performing the anthropometry examined 20 other neonates; all of whom were born after ≥38 weeks gestation. In this standardization training, 7 female infants and 13 male infants were measured twice by each observer. A sufficient time interval (30 minutes) was allotted between each measurement so that the second would not be influenced by the observer's memory of the first. These data were used to examine the reliability of measures and sources of variance.
The reliability of the anthropometric measures was calculated as the Pearson correlation coefficient between the paired measures. The observations taken by the two observers were not statistically different when compared using a paired t-test (results not shown). Analysis of variance (ANOVA) with a random effect term for subject was used to estimate between-subject, between-observer, and within-observer components of variance, by sex.
For the main study, a linear regression analysis was used to evaluate birth weight, birth length, and gestational age as predictors of AGD. Age of the mother, number of pregnancies, and time elapsed between birth and measurement were not important predictors (or confounders) of AGD in univariate or multivariate models and were not considered further in the analysis. To examine influential values and the overall fit of the model, we conducted an analysis of residuals, but found nothing of note.
The protocol was approved by human subjects committees at the National Institute of Public Health in Mexico and the National Institute of Environmental Health Sciences in the U.S.
Mean, coefficient of variation (CV), and reliability of anthropometric measurements in 20 newbornsa
Head Circumference (cm)
Distribution of selected characteristics in 87 newborns, Mexico, 1999a
Female n = 42
Male n = 45
Anogenital distance (mm)
Head circumference (cm)
Regression coefficients for anogenital distance as a function of characteristics at birth, femalesa
Regression coefficients for anogenital distance as a function of characteristics at birth, malesa
The AGD measures employed in the present study reflect the location of the caudal border of the genital swelling, an embryologic structure that differentiates into the labia majora in females and the scrotum in males. After the indifferent stage of the external genitalia, the critical events determining the sexual dimorphism of AGD in humans begin when, relative to the anus, the genital swelling, urethral folds, and possibly the genital tubercle, move ventrally under the influence of androgens . Elongation of the genital tubercle, which becomes the phallus, also occurs at this time. The difference between males and females in our data demonstrates sexual dimorphism of this particular measure of AGD. The two-fold difference in the aspect of AGD that we measured is not reflected in the schematic diagrams of human sexual differentiation we have seen [29, 30], which is likely due to the previous lack of formal measures.
Direct comparison of our results with those in the two other studies with measures of anus-to-fourchette (AF) distance in female newborns [24, 25] is hampered by different eligibility criteria, and possibly different ethnicities, in the three studies. For example, Callegari et al.'s subjects had a mean weight of 2,530 g; Phillips et al. did not present mean birth weight but subjects were required to have a birth weight above 2,750 g; and in our study the mean birth weight among females was 3,060 g. The mean AF distance in the Callegari et al. study was 10.9 mm; in the Phillips et al. study was 16.1 mm in Jews and 16.5 in Bedouins, and in the present study was 11 mm. Callegari reported no ethnic differences in their population (62.6% Hispanic, 28.7% black, and 8.7% white). Despite the ethnic-specific mean values noted above, Phillips et al. reported that Jewish females had a greater AF distance than did Bedouins. The similarity of the mean AF distance measures in the present study and the Callegari et al. study is surprising given the difference in mean birth weights, and suggests ethnic differences, or a systematic difference in how the measurements were done.
Compared with established anthropometric measures on newborns, the reliability of the AGD measures were lower. The lower reliability of the AGD measures is likely due to several factors. The AGD measures depend on indistinct landmarks on soft tissues. Structures such as "the center of the anus" or the posterior fourchette are not clearly demarcated. Any slight traction or pressure applied to the perineum or surrounding structures could alter measures. Finally, compared with established anthropometric measures on newborns, the AGD dimensions are smaller, thus measures done with the naked eye on a subject unlikely to hold still are inherently at a disadvantage. Use of two observers, one to restrain the subject and one to do the measurements could result in improved reliability compared to our approach, which employed one observer.
Compared with adult humans, the size of the genitals at birth is large relative to the body overall . Yet the genital size is, of course, still determined in part by overall body dimensions and age. The need to adjust AGD for overall body dimension is well known in animal experiments . In humans, the best approach to such adjustment remains unclear. Our data suggest that for the aspect of AGD we measured, adjustment for body weight is reasonable.
A complete assessment of AGD in humans would include more measurements than were done in our study. In neonatal rodents, measurement of AGD is relatively straightforward and is the distance from the genital tubercle to the anus. In older animals or humans of any age, however, questions arise as to which measure is most informative. For example, in human males, rather than a genital tubercle, the presence of the phallus and testicles at birth means that a number of measurements are possible. The measurement in the present study, from the posterior scrotal-perineal junction, represents only one such measurement. Ideally we would have done genital tubercle measurements in males and females, but we did not. Whether sexual dimorphism exists in the distance from the anus to the genital tubule (penile base in males) would be useful to know. While one might expect that penile length may be a good measure of androgenization among males, difficulties obtaining a reliable measure mean that alternative measures, such as AGD, are worth investigating.
Effects of endocrinopathies on AGD in humans have been described, but only to a limited degree. A rare form of congenital adrenal hyperplasia that causes incomplete masculine development has been reported to cause decreased AGD in boys . Details on how the measurement was done (and the measured values), however, were not presented [22, 23]. Callegari et al.  measured the distance from the anus to the fourchette (same as what we did) and in addition measured the distance from the anus to the clitoris; the ratio of these two measures in three newborn females with congenital adrenal hyperplasia was increased relative to normal newborn females. Earlier case reports on females with adrenogenital syndrome noted labiosacral fusion, but again, no formal measures were published . The utility of AGD measures in humans is further supported by experimental data in primates showing that in utero exposure of females to androgenic agents increased AGD .
The purported mechanism by which androgens increase AGD in females is by inducing "labioscrotal fusion" (in normal males fusion begins caudally and proceeds ventrally, presumably androgens in females act the same way) . This mechanism, however, does not account for why males who are not fully androgenized would have a decreased AGD, unless AGD in males is defined as being from tip of penis to the center of the anus. A set of formal AGD measures on subjects with selected congenital endocrinopathies or birth defects could be useful in evaluating whether this outcome is uniformly responsive to gross stimuli, and may help discern details of normal embryology and the consequences of disrupting it.
In summary, we have shown that an aspect of genital dimension that reflects migration of the genital swelling is sexually dimorphic in humans. Whether this particular measure, or other measures of AGD in humans, has any utility as markers of exposure in utero to hormonally active agents remains to be seen.
analysis of variance
We are grateful to Alma Gonzalez-Rodriquez, MD, from the Instituto Nacional de Salud Publica, Cuernavaca, Mexico, for taking the anthropometric measurements of the infants, to the administrators of Dr. Ernesto Meana San Román General Hospital in Jojutla, Morelos, Mexico, for their cooperation and support, and to Grace Kissling, PhD, for statistical support.
- Hendrickx AG, Korte R, Leuschner F, Neumann BW, Prahalada S, Poggel A, Binkerd PE, Gunzel P: Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus). Teratology. 1987, 35: 119-127.View ArticleGoogle Scholar
- Gray LE, Ostby JS, Kelce WR: Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol Appl Pharmaco. 1994, 129: 46-52. 10.1006/taap.1994.1227.View ArticleGoogle Scholar
- You L, Casanova M, Archibeque-Engle S, Sar M, Fan LQ, Heck HA: Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans hooded rats exposed in utero and lactationally to p,p'-DDE. Toxicol Sci. 1998, 45: 62-73. 10.1006/toxs.1998.2515.Google Scholar
- Mylchreest E, Sar M, Cattley RC, Foster PM: Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol. 1999, 156: 81-95. 10.1006/taap.1999.8643.View ArticleGoogle Scholar
- Gray LE, Wolf C, Lambright C, Mann P, Price M, Cooper RL, Ostby J: Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health. 1999, 15: 94-118. 10.1191/074823399678846664.View ArticleGoogle Scholar
- Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray LE: The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol Ind Health. 1999, 15: 80-93. 10.1191/074823399678846718.View ArticleGoogle Scholar
- McIntyre BS, Barlow NJ, Wallace DG, Maness SC, Gaido KW, Foster PM: Effects of in utero exposure to linuron on androgen-dependent reproductive development in the male Crl:CD(SD)BR rat. Toxicol Appl Pharmacol. 2000, 167: 87-99. 10.1006/taap.2000.8998.View ArticleGoogle Scholar
- Nagao T, Ohta R, Marumo H, Shindo T, Yoshimura S, Ono H: Effect of butyl benzyl phthalate in Sprague-Dawley rats after gavage administration: a two-generation reproductive study. Reprod Toxicol. 2000, 14: 513-532. 10.1016/S0890-6238(00)00105-2.View ArticleGoogle Scholar
- Fielden MR, Halgren RG, Tashiro CH, Yeo BR, Chittim B, Chou K, Zacharewski TR: Effects of gestational and lactational exposure to Aroclor 1242 on sperm quality and in vitro fertility in early adult and middle-aged mice. Reprod Toxicol. 2001, 15: 281-292. 10.1016/S0890-6238(01)00129-0.View ArticleGoogle Scholar
- McIntyre BS, Barlow NJ, Foster PM: Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. Toxicol Sci. 2001, 62: 236-249. 10.1093/toxsci/62.2.236.View ArticleGoogle Scholar
- Gray LE, Ostby J, Furr J, Wolf CJ, Lambright C, Parks L, Veeramachaneni DN, Wilson V, Price M, Hotchkiss A, Orlando E, Guillette L: Effects of environmental antiandrogens on reproductive development in experimental animals. Hum Reprod Update. 2001, 7: 248-264. 10.1093/humupd/7.3.248.View ArticleGoogle Scholar
- McIntyre BS, Barlow NJ, Foster PM: Male rats exposed to linuron in utero exhibit permanent changes in anogenital distance, nipple retention, and epididymal malformations that result in subsequent testicular atrophy. Toxicol Sci. 2002, 65: 62-70. 10.1093/toxsci/65.1.62.View ArticleGoogle Scholar
- Shimamura M, Kodaira K, Kenichi H, Ishimoto Y, Tamura H, Iguchi T: Comparison of antiandrogenic activities of vinclozolin and D,L-camphorquinone in androgen receptor gene transcription assay in vitro and mouse in utero exposure assay in vivo. Toxicology. 2002, 174: 97-107. 10.1016/S0300-483X(02)00044-6.View ArticleGoogle Scholar
- Miyata K, Yabushita S, Sukata T, Sano M, Yoshino H, Nakanishi T, Okuno Y, Matsuo M: Effects of perinatal exposure to flutamide on sex hormones and androgen-dependent organs in F1 male rats. J Toxicol Sci. 2002, 27: 19-33.View ArticleGoogle Scholar
- Wang XQ, Fang J, Nunez AA, Clemens LG: Developmental exposure to polychlorinated biphenyls affects sexual behavior of rats. Physiol Behav. 2002, 75: 689-696. 10.1016/S0031-9384(02)00673-X.View ArticleGoogle Scholar
- Turner KJ, Barlow NJ, Struve MF, Wallace DG, Gaido KW, Dorman DC, Foster PM: Effects of in utero exposure to the organophosphate insecticide fenitrothion on androgen-dependent reproductive development in the Crl:CD(SD)BR rat. Toxicol Sci. 2002, 68: 174-183. 10.1093/toxsci/68.1.174.View ArticleGoogle Scholar
- Bowman CJ, Barlow NJ, Turner KJ, Wallace DG, Foster PM: Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat. Toxicol Sci. 2003, 74: 393-406. 10.1093/toxsci/kfg128.View ArticleGoogle Scholar
- Marty MS, Chapin RE, Parks LG, Thorsrud BA: Development and maturation of the male reproductive system. Birth Defects Res Part B Dev Reprod Toxicol. 2003, 68: 125-136.View ArticleGoogle Scholar
- Gallavan RH, Holson JF, Stump DG, Knapp JF, Reynolds VL: Interpreting the toxicologic significance of alterations in anogenital distance: potential for confounding effects of progeny body weights. Reprod Toxicol. 1999, 13: 383-390. 10.1016/S0890-6238(99)00036-2.View ArticleGoogle Scholar
- Gray LE, Ostby J, Monosson E, Kelce WR: Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol Ind Health. 1999, 15: 48-64. 10.1191/074823399678846646.View ArticleGoogle Scholar
- Goldman AS, Bongiovanni AM: Induced genital anomalies. Ann N Y Acad Sci. 1967, 142: 755-767.View ArticleGoogle Scholar
- Bongiovanni AM, Root AW: The adrenogenital syndrome. N Engl J Med. 1963, 268: 1283-9. 1342–1351View ArticleGoogle Scholar
- Bongiovanni AM, Kellenbenz G: The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase. J Clin Invest. 1962, 41: 2086-2092.View ArticleGoogle Scholar
- Callegari C, Everett S, Ross M, Brasel JA: Anogenital ratio: measure of fetal virilization in premature and full-term newborn infants. J Pediatr. 1987, 111: 240-243.View ArticleGoogle Scholar
- Phillip M, De Boer C, Pilpel D, Karplus M, Sofer S: Clitoral and penile sizes of full term newborns in two different ethnic groups. J Pediatr Endocrinol Metab. 1996, 9: 175-179.View ArticleGoogle Scholar
- Dubowitz LM, Dubowitz V, Goldberg C: Clinical assessment of gestational age in the newborn infant. J Pediatr. 1970, 77: 1-10.View ArticleGoogle Scholar
- Flegal KM, Launer LJ, Graubard BI, Kestler E, Villar J: Modeling maternal weight and height in studies of pregnancy outcome among Hispanic women. Am J Clin Nutr. 1993, 58: 145-151.Google Scholar
- Langman J: Medical Embryology: Human development – Normal and Abnormal. 1975, Baltimore: The Williams & Wilkins Company, 160-200. 3Google Scholar
- Hannon TS, Fuqua JS: Sexual differentiation. In: Developmental Endocrinology. Edited by: Eugster EA, Pescovitz OH. 2002, Totowa, NJ: Humana Press, 261-291.Google Scholar
- Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS: Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev. 1995, 16: 271-321. 10.1210/er.16.3.271.Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1476-069x/3/8/prepub
This article is published under license to BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.